Lifesciences Outlook For 2016 – CMS Conference Report

United Kingdom

On February 2nd 2016, CMS hosted a conference on key trends in the lifesciences sector and the outlook for 2016.

A keynote speaker from the Association of the British Pharmaceutical Industry (ABPI) as well as CMS legal experts provided thought provoking insight on the current environment for lifesciences businesses in the UK, the first UK Deferred Prosecution Agreement, the collapse of the US Safe Harbour, how to respond to a cybersecurity breach, the regulatory landscape, and the growing market for apps and wearables and the legal issues and challenges this raises.

This report provides a snapshot of the discussions which took place on the day.

If you would like to discuss any of the issues raised in this report or wish to provide any feedback, please contact Sarah Hanson (Head of UK Lifesciences), the relevant speaker(s), or your usual contact at CMS.